Mirage or long-awaited oasis: reinvigorating T-cell responses in pancreatic cancer

Pancreatic ductal adenocarcinoma (PDAC) is plagued by a dismal 5-year survival rate, early onset of metastasis and limited efficacy of systemic therapies. This scenario highlights the need to fervently pursue novel therapeutic strategies to treat this disease. Recent research has uncovered complicat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ware, Michael Brandon, El-Rayes, Bassel F, Lesinski, Gregory B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449491/
https://www.ncbi.nlm.nih.gov/pubmed/32843336
http://dx.doi.org/10.1136/jitc-2020-001100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449491/
https://www.ncbi.nlm.nih.gov/pubmed/32843336
http://dx.doi.org/10.1136/jitc-2020-001100

Ejemplares similares